A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma

-

Location(s): United States

Description

Pembrolizumab alone and in combination with ACP-196 in subjects with advanced non-small cell lung cancer.